Latest news with #AED2.06B
Yahoo
15-04-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Over US$0
Most Gulf markets have recently experienced gains, supported by easing trade tensions following U.S. tariff exemptions on certain electronics, which has positively influenced indices across the region. For investors interested in exploring beyond the well-known companies, penny stocks—despite their somewhat outdated name—remain a relevant area of interest. These smaller or newer companies often possess solid financial foundations and potential for significant returns, offering intriguing opportunities for those willing to explore them further. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.04 SAR1.62B ★★★★★★ Keir International (SASE:9542) SAR3.93 SAR471.6M ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪2.782 ₪192.91M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.949 ₪2.95B ★★★★★☆ Tarya Israel (TASE:TRA) ₪0.578 ₪171.58M ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.173 ₪161.55M ★★★★★★ Union Properties (DFM:UPP) AED0.523 AED2.26B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.735 AED450.11M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.02 AED2.06B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.44 AED10.37B ★★★★☆☆ Click here to see the full list of 96 stocks from our Middle Eastern Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Apex Investment PSC manufactures, distributes, and sells clinkers and cement products in the United Arab Emirates and internationally, with a market cap of AED14.50 billion. Operations: The company's revenue is primarily derived from its Catering segment at AED595.66 million, followed by Manufacturing at AED235.34 million, Facility Management Services at AED106.16 million, and Contracting at AED38.01 million within the United Arab Emirates and beyond. Market Cap: AED14.5B Apex Investment PSC has shown a significant turnaround by becoming profitable in the past year, reporting net income of AED75.64 million for 2024 compared to a net loss the previous year. With sales reaching AED852.85 million, the company's primary revenue streams are its Catering and Manufacturing segments. Apex's balance sheet is strong with no debt and short-term assets exceeding both short and long-term liabilities, providing financial stability. However, its earnings were impacted by a large one-off loss of AED57.9 million, and its Return on Equity remains low at 3.8%. The stock has experienced high volatility recently but maintains stable weekly volatility over the past year. Navigate through the intricacies of Apex Investment PSC with our comprehensive balance sheet health report here. Assess Apex Investment PSC's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Ihlas Holding A.S. operates in construction and real estate, media, manufacturing and trading, as well as healthcare and education sectors both in Turkey and internationally, with a market cap of TRY3.34 billion. Operations: The company's revenue is primarily derived from marketing (TRY4.22 billion), media (TRY2.29 billion), and construction (TRY1.88 billion) sectors. Market Cap: TRY3.34B Ihlas Holding A.S. has demonstrated financial resilience despite reporting a net loss of TRY1.38 billion for 2024, compared to a net income the previous year. The company's debt management is commendable, with its debt-to-equity ratio significantly reduced to 4.9% over five years and more cash on hand than total debt. Short-term assets of TRY13.7 billion cover both short and long-term liabilities, indicating robust liquidity. However, Ihlas remains unprofitable with a negative return on equity of -18.34%. Management stability is evident with an experienced team averaging 13.3 years in tenure, though share price volatility persists recently. Click here and access our complete financial health analysis report to understand the dynamics of Ihlas Holding. Evaluate Ihlas Holding's historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Imed Infinity Medical-Limited Partnership is a research and development partnership that invests in medical field projects, particularly in digital health, with a market cap of ₪3.65 million. Operations: Imed Infinity Medical-Limited Partnership has not reported any revenue segments. Market Cap: ₪3.65M Imed Infinity Medical-Limited Partnership, with a market cap of ₪3.65 million, is a pre-revenue entity focused on digital health projects. Despite being debt-free and having short-term assets ($896K) that exceed liabilities ($112K), the company remains unprofitable with losses increasing by 15.8% annually over five years. Recent earnings results show an improvement in net loss to US$0.575 million from US$1.77 million the previous year, reflecting reduced basic and diluted loss per share from continuing operations at US$0.14 compared to US$0.44 prior year-end December 2024, indicating some cost management progress amidst ongoing challenges. Dive into the specifics of Imed Infinity Medical-Limited Partnership here with our thorough balance sheet health report. Examine Imed Infinity Medical-Limited Partnership's past performance report to understand how it has performed in prior years. Click through to start exploring the rest of the 93 Middle Eastern Penny Stocks now. Ready To Venture Into Other Investment Styles? These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:APEX IBSE:IHLAS and TASE:IMED. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
14-04-2025
- Business
- Yahoo
Middle Eastern Gems: Tukas Gida Sanayi ve Ticaret And 2 Other Promising Penny Stocks
Most Gulf markets have recently extended their gains, buoyed by temporary U.S. tariff relief, though global trade uncertainties continue to loom large. In this context, investing in penny stocks — a term that may seem outdated but remains relevant — can still offer intriguing opportunities for growth, particularly in smaller or emerging companies. By focusing on those with strong financial health and potential for stability and upside, investors can discover promising prospects among these often-overlooked stocks. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.04 SAR1.58B ★★★★★★ Keir International (SASE:9542) SAR3.93 SAR463.2M ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪2.378 ₪164.89M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.923 ₪2.87B ★★★★★☆ Tarya Israel (TASE:TRA) ₪0.578 ₪171.58M ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.189 ₪162.74M ★★★★★★ Union Properties (DFM:UPP) AED0.516 AED2.21B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.74 AED450.11M ★★★★★★ E7 Group PJSC (ADX:E7) AED0.99 AED2.06B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.41 AED10.25B ★★★★☆☆ Click here to see the full list of 98 stocks from our Middle Eastern Penny Stocks screener. Let's dive into some prime choices out of the screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Tukas Gida Sanayi ve Ticaret A.S. manufactures and sells food products both in Turkey and internationally, with a market capitalization of TRY9.81 billion. Operations: The company generates revenue primarily from its food processing segment, which amounts to TRY6.84 billion. Market Cap: TRY9.81B Tukas Gida Sanayi ve Ticaret A.S. has demonstrated a reduction in its debt to equity ratio from 129.6% to 28.8% over five years, suggesting improved financial stability. However, earnings growth has been negative recently, with net profit margins declining from 17.9% to 11.4%. The company's price-to-earnings ratio of 12.6x is below the Turkish market average, indicating potential undervaluation despite low return on equity at 6.9%. While short-term assets comfortably cover liabilities and the board is experienced with an average tenure of over ten years, operating cash flow remains negative and interest coverage is insufficient at 2.9x EBIT. Dive into the specifics of Tukas Gida Sanayi ve Ticaret here with our thorough balance sheet health report. Evaluate Tukas Gida Sanayi ve Ticaret's historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Alinma Retail REIT Fund is a real estate investment fund with a market cap of SAR534.54 million. Operations: The fund generates revenue primarily from its real estate rental activities, amounting to SAR187.74 million. Market Cap: SAR534.54M Alinma Retail REIT Fund, with a market cap of SAR534.54 million, has shown financial improvement by becoming profitable over the past year and reporting net income of SAR8.13 million for 2024, compared to a loss the previous year. Revenue increased significantly to SAR187.74 million from SAR51.63 million year-on-year, driven by real estate rental activities. The fund's debt is well covered by operating cash flow at 31.3%, although short-term assets do not cover long-term liabilities of SAR263.3 million fully. Despite low return on equity at 1%, it trades below estimated fair value and maintains dividend distributions totaling SAR0.32 per unit annually. Unlock comprehensive insights into our analysis of Alinma Retail REIT Fund stock in this financial health report. Examine Alinma Retail REIT Fund's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Oil Refineries Ltd. operates in the production and sale of fuel products, intermediate materials, and aromatic products both in Israel and internationally, with a market cap of ₪2.87 billion. Operations: The company generates revenue from its segments, with $6.73 billion coming from refining and $806 million from polymers. Market Cap: ₪2.87B Oil Refineries Ltd., with a market cap of ₪2.87 billion, recently reported a decline in sales to US$7.54 billion and net income to US$113 million for 2024, reflecting challenges in profitability as profit margins dropped from 4.9% to 1.5%. Despite this, the company maintains strong liquidity with short-term assets exceeding both short- and long-term liabilities. Its debt management has improved significantly over five years, reducing the debt-to-equity ratio from over 100% to a satisfactory level of 22.2%. However, dividend sustainability is questionable due to insufficient earnings coverage, and interest payments are not well covered by EBIT. Get an in-depth perspective on Oil Refineries' performance by reading our balance sheet health report here. Explore historical data to track Oil Refineries' performance over time in our past results report. Reveal the 98 hidden gems among our Middle Eastern Penny Stocks screener with a single click here. Ready For A Different Approach? AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:TUKAS SASE:4345 and TASE:ORL. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
10-04-2025
- Business
- Yahoo
3 Middle Eastern Penny Stocks With At Least US$100M Market Cap
As global trade tensions continue to impact markets, many Gulf indices have seen declines, reflecting broader economic uncertainties. Despite these challenges, the Middle Eastern market remains a fertile ground for investment opportunities, particularly in the realm of penny stocks. While often overlooked and considered outdated by some, penny stocks represent smaller or newer companies that can offer substantial growth potential when backed by strong financials. In this article, we explore three such stocks that stand out for their promising prospects and robust balance sheets. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR3.85 SAR1.54B ★★★★★★ Keir International (SASE:9542) SAR3.85 SAR462M ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪2.243 ₪155.53M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.90 ₪2.8B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.183 ₪162.29M ★★★★★★ Union Properties (DFM:UPP) AED0.519 AED2.23B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.738 AED431.86M ★★★★★★ Al Ansari Financial Services PJSC (DFM:ALANSARI) AED0.973 AED7.27B ★★★★☆☆ E7 Group PJSC (ADX:E7) AED1.03 AED2.06B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.36 AED9.99B ★★★★☆☆ Click here to see the full list of 98 stocks from our Middle Eastern Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Bank Of Sharjah P.J.S.C. operates as a provider of commercial and investment banking products and services in the United Arab Emirates, with a market capitalization of AED2.82 billion. Operations: The company's revenue is derived from two primary segments: Commercial Banking, contributing AED315.01 million, and Investment Banking, generating AED262.69 million. Market Cap: AED2.82B Bank Of Sharjah P.J.S.C. has recently turned profitable, reporting a net income of AED 385 million for 2024 compared to a loss the previous year. The bank's price-to-earnings ratio of 7.3x suggests it is valued below the broader AE market average, potentially appealing to value investors. Despite having an appropriate Loans to Deposits ratio (75%) and primarily low-risk funding sources, the bank faces challenges with high bad loans at 8.1%. The management team is relatively new with an average tenure of just 0.3 years, which may impact strategic continuity and execution moving forward. Click here to discover the nuances of Bank Of Sharjah P.J.S.C with our detailed analytical financial health report. Evaluate Bank Of Sharjah P.J.S.C's historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Amanat Holdings PJSC, with a market cap of AED2.67 billion, invests in companies and enterprises within the education and healthcare sectors both in the United Arab Emirates and internationally. Operations: The company's revenue is derived from AED432.26 million in the education sector and AED363.84 million in healthcare. Market Cap: AED2.67B Amanat Holdings PJSC, with a market cap of AED2.67 billion, has shown significant improvement in financial performance, reporting AED 796.1 million in sales and a net income of AED 115.84 million for 2024 compared to a loss the previous year. The company's earnings growth of 191.4% over the past year outpaced industry averages despite a historical decline over five years. Although its Return on Equity is low at 6.2%, Amanat maintains strong short-term asset coverage and interest payment capabilities while managing debt effectively with more cash than total debt, though dividend sustainability remains an area for concern given free cash flow constraints. Take a closer look at Amanat Holdings PJSC's potential here in our financial health report. Examine Amanat Holdings PJSC's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Novolog (Pharm-Up 1966) Ltd is a healthcare services provider in Israel with a market cap of ₪730.50 million. Operations: No revenue segments have been reported for this healthcare services provider in Israel. Market Cap: ₪730.5M Novolog (Pharm-Up 1966) Ltd, with a market cap of ₪730.50 million, has transitioned to profitability this year, reporting sales of ₪2.02 billion for 2024 and a net income of ₪39.54 million compared to a loss the previous year. Despite its low Return on Equity at 10.7%, the company benefits from being debt-free and having experienced management and board members with average tenures of over four years. While short-term liabilities slightly exceed assets by ₪100 million, high-quality earnings and stable weekly volatility underscore its financial resilience amidst challenges in dividend coverage by earnings. Navigate through the intricacies of Novolog (Pharm-Up 1966) with our comprehensive balance sheet health report here. Assess Novolog (Pharm-Up 1966)'s previous results with our detailed historical performance reports. Take a closer look at our Middle Eastern Penny Stocks list of 98 companies by clicking here. Looking For Alternative Opportunities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:BOS DFM:AMANAT and TASE:NVLG. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
09-04-2025
- Business
- Yahoo
Middle Eastern Penny Stocks To Watch In April 2025
The Middle Eastern stock markets have recently shown resilience, with Gulf bourses rebounding alongside global shares and indices like Saudi Arabia's benchmark experiencing notable recovery. For investors looking beyond well-known names, penny stocks—often representing smaller or newer companies—remain an intriguing area of investment. Despite the term's historical connotations, these stocks can offer substantial opportunities when backed by strong financials and growth potential. In this article, we explore three such penny stocks in the Middle East that combine balance sheet strength with promising prospects for those interested in uncovering hidden value. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR3.93 SAR1.57B ★★★★★★ Keir International (SASE:9542) SAR3.88 SAR465.6M ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪2.361 ₪163.71M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.908 ₪2.82B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.184 ₪162.36M ★★★★★★ Union Properties (DFM:UPP) AED0.511 AED2.19B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.701 AED426.39M ★★★★★★ Al Ansari Financial Services PJSC (DFM:ALANSARI) AED0.958 AED7.16B ★★★★☆☆ E7 Group PJSC (ADX:E7) AED1.04 AED2.06B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.35 AED9.99B ★★★★☆☆ Click here to see the full list of 98 stocks from our Middle Eastern Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Duran Dogan Basim ve Ambalaj Sanayi A.S. operates in the packaging industry, offering products across Turkey and various international markets, with a market cap of TRY1.87 billion. Operations: The company generates revenue solely from its Packaging & Containers segment, amounting to TRY2.00 billion. Market Cap: TRY1.87B Duran Dogan Basim ve Ambalaj Sanayi A.S., with a market cap of TRY1.87 billion, operates in the packaging industry and reported revenue of TRY2.00 billion for 2024, though it incurred a net loss of TRY159.2 million compared to a profit the previous year. The company's debt situation has improved significantly over five years, reducing its debt-to-equity ratio from 156.8% to 37.6%, and its net debt is satisfactorily covered by operating cash flow at 45.1%. While unprofitable, Duran Dogan has reduced losses annually by 26.2% over five years and maintains seasoned board leadership with an average tenure of nearly 11 years. Take a closer look at Duran Dogan Basim ve Ambalaj Sanayi's potential here in our financial health report. Understand Duran Dogan Basim ve Ambalaj Sanayi's track record by examining our performance history report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Matricelf Ltd (TASE:MTLF) is a biotechnology company focused on developing a platform for autologous tissue engineering to address various medical conditions, with a market cap of ₪46.16 million. Operations: Matricelf Ltd has not reported any revenue segments. Market Cap: ₪46.16M Matricelf, a biotechnology firm with a market cap of ₪46.16 million, is currently pre-revenue and unprofitable, focusing on pioneering regenerative therapies. A recent collaboration with Cellino aims to advance personalized spinal cord injury treatments by integrating cutting-edge biomanufacturing technologies. This strategic partnership has enabled Matricelf to transform induced pluripotent stem cells into functional neural tissues, marking significant progress in regenerative medicine. Despite having no debt and short-term assets exceeding liabilities, the company faces financial constraints with less than a year of cash runway. Its management team is experienced; however, the board lacks tenure depth. Get an in-depth perspective on Matricelf's performance by reading our balance sheet health report here. Explore historical data to track Matricelf's performance over time in our past results report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Ratio Petroleum Energy - Limited Partnership is involved in the exploration, development, and production of oil and gas, with a market capitalization of ₪67.45 million. Operations: No revenue segments have been reported for this company. Market Cap: ₪67.45M Ratio Petroleum Energy - Limited Partnership, with a market cap of ₪67.45 million, is pre-revenue and currently unprofitable, reporting a net loss of US$4.18 million for 2024. Despite its financial challenges, the company benefits from being debt-free and having short-term assets ($5.1M) that cover both short-term ($1.1M) and long-term liabilities ($131K). However, it faces volatility issues with a fluctuating share price over the past months and less than a year of cash runway if free cash flow continues to grow at historical rates. The board is experienced with an average tenure of 8.4 years. Jump into the full analysis health report here for a deeper understanding of Ratio Petroleum Energy - Limited Partnership. Evaluate Ratio Petroleum Energy - Limited Partnership's historical performance by accessing our past performance report. Take a closer look at our Middle Eastern Penny Stocks list of 98 companies by clicking here. Ready To Venture Into Other Investment Styles? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:DURDO TASE:MTLF and TASE:RTPT. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
